相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determinants of costs of care for patients with Alzheimer's disease
Linus Jonsson et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Global prevalence of dementia: a Delphi consensus study
CP Ferri et al.
LANCET (2005)
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials
H Kaduszkiewicz et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease
H Brodaty et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)
Cost effectiveness of cholinesterase inhibitors in the treatment of Alzheimer's disease - A review with methodological considerations
A Wimo
DRUGS & AGING (2004)
Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK
A Ward et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States
K Migliaccio-Walle et al.
CLINICAL THERAPEUTICS (2003)
Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications
C Holmes et al.
AGE AND AGEING (2003)
Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands
JJ Caro et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2002)
Assessment of health economics in Alzheimer's disease (AHEAD) - Treatment with galantamine in Sweden
FB Garfield et al.
PHARMACOECONOMICS (2002)
Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care
JJ Caro et al.
NEUROLOGY (2001)
Assessment of health economics in Alzheimer's disease (AHEAD) - Galantamine treatment in Canada
D Getsios et al.
NEUROLOGY (2001)
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
B Winblad et al.
NEUROLOGY (2001)
A 5-month, randomized, placebo-controlled trial of galantamine in AD
PN Tariot et al.
NEUROLOGY (2000)
A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease
M Farlow et al.
EUROPEAN NEUROLOGY (2000)
分享论文
